Jean-François Yale, MD
Primary Axis:
Endocrinology, Diabetes, Nutrition and Kidney Diseases Research Focus:
Clinical trials: diabetes prevention (DREAM, NAVIGATOR), inhaled insulin (EXUBERA), thiazolidinediones, basal insulin, glucose monitoring devices, intensive management of diabetes (ACCORD), prevention of hypoglycemia. Computerization of health care (MOXXI, IRIS).
Keywords:
Diabetes, hypoglycemia, insulin, health care organization, prevention, computerization
Location:
Royal Victoria Hospital Publications:
Kalergis M, Schiffrin A, Gougeon R, Jones PJH and Yale JF. Impact of bedtime snack on prevention of nocturnal hypoglycemia in adults with type 1 diabetes mellitus undergoing intensive insulin management using Lispro insulin AC meals : A randomized placebo-controlled, crossover, inpatient trial. Diabetes Care 26 : 9-15, 2003.
Nadeau J, Koski KG, Strychar I and Yale JF. Teaching Subjects with Type 2 Diabetes How to Incorporate Sugar Choices Into Their Daily Meal Plan Promotes Dietary Compliance and Does Not Deteriorate Metabolic Profile. Diabetes Care 24: 222-227, 2001.
Yale JF, Valiquett TR, Ghazzi MN et al. The Effect of a Thiazolidinedione Drug, Troglitazone, on Glycemia in Patients with Type 2 Diabetes Mellitus Poorly Controlled with Sulfonylurea and Metformin. Annals of Internal Medicine 134: 737- 745, 2001
